Table of Contents
- Why Vertebral Compression Fractures Are a High-Yield Pain Medicine Topic
- Clinical Presentation and Diagnostic Workup
- Staging and Classification Systems
- Conservative Management Before Considering a Procedure
- Percutaneous Vertebroplasty: Step-by-Step Technique
- Balloon Kyphoplasty: Step-by-Step Technique
- Comparing Vertebroplasty, Kyphoplasty, and Conservative Management
- What the Landmark Trials Show: Buchbinder, Kallmes, and VAPOUR
- Complications and Risk Mitigation
- Keep Learning
- FAQs
Vertebral compression fracture treatment decisions sit at the intersection of osteoporosis management, interventional pain medicine, and board-exam testable material, which makes this topic a near-certain high-yield area for the ABA Pain Medicine exam. Roughly 1.5 million osteoporotic vertebral compression fractures occur annually in the United States, yet fewer than a third are ever clinically diagnosed, and the choice between conservative care, vertebroplasty, and balloon kyphoplasty remains one of the more nuanced evidence-based decisions a pain physician will face. This review walks through the pathophysiology, diagnostic workup, staging, procedural technique, and the (sometimes contradictory) randomized trial evidence that every pain fellow and board candidate should know cold.
Why Vertebral Compression Fractures Are a High-Yield Pain Medicine Topic
A vertebral compression fracture occurs when the anterior or lateral column of a vertebral body collapses under axial load, most commonly in osteoporotic bone but also from malignancy, trauma, or steroid-induced osteopenia. Thoracolumbar junction levels (T11-L2) bear the highest mechanical stress and account for the majority of fractures. Once a patient sustains one osteoporotic compression fracture, the risk of a second fracture within one year rises roughly fivefold, which is why every workup for vertebral compression fracture treatment should also trigger a secondary osteoporosis evaluation (DEXA, vitamin D, calcium, and consideration of anti-resorptive or anabolic therapy) rather than treating the fracture in isolation.
Biomechanically, an acute wedge or biconcave deformity increases kyphotic load on adjacent levels, which is the mechanistic argument for early stabilization in appropriately selected patients. Chronic unrecognized fractures contribute to progressive kyphosis, restrictive lung physiology, and increased one-year mortality after hip and vertebral fragility fractures alike, so the stakes of accurate diagnosis and timely vertebral compression fracture treatment are higher than the "just a backache" framing many patients arrive with.
Clinical Presentation and Diagnostic Workup
Classic presentation is acute-onset midline back pain after a seemingly trivial event (a cough, a sneeze, bending to pick something up) or, less commonly, after a clear fall. Pain is typically axial, worse with standing and flexion, and relieved by lying supine. Point tenderness over the spinous process at the involved level is common. Red flags that should prompt urgent escalation include fever, unexplained weight loss, a known malignancy history, progressive neurologic deficit, or bowel/bladder dysfunction, any of which shift the differential toward pathologic fracture, epidural abscess, or metastatic disease rather than routine osteoporotic collapse.
Plain radiographs are a reasonable first step for suspected vertebral compression fracture treatment candidates but cannot reliably distinguish an acute fracture from an old, healed one. MRI with STIR (short tau inversion recovery) sequences is the key diagnostic tool: bone marrow edema on STIR confirms the fracture is acute and physiologically "hot," which matters enormously for vertebral compression fracture treatment planning, since trial evidence (discussed below) suggests procedural benefit is concentrated in recently symptomatic fractures. A technetium-99m bone scan is a reasonable alternative when MRI is contraindicated. CT is useful for surgical planning and for assessing posterior wall integrity before any cement augmentation procedure.
Staging and Classification Systems
Board exams favor the Genant semiquantitative classification, which grades vertebral height loss as mild (Grade 1, 20-25% loss), moderate (Grade 2, 25-40% loss), or severe (Grade 3, greater than 40% loss), based on anterior, middle, and posterior vertebral body height measured on lateral imaging. The AO Spine Thoracolumbar Injury Classification is more relevant to traumatic fractures and separates compression (A), distraction (B), and translation (C) injury patterns, with subtypes guiding whether posterior ligamentous integrity is preserved. For osteoporotic fractures specifically, the German Spine Society's OF (Osteoporotic Fracture) classification layers morphology with the presence of posterior wall involvement and instability, which helps triage who is a vertebroplasty/kyphoplasty candidate versus who needs surgical consultation. Knowing which classification applies to which fracture mechanism, and how it shapes the vertebral compression fracture treatment plan, is a common board discriminator.
Conservative Management Before Considering a Procedure
Most osteoporotic compression fractures are managed nonoperatively first: short-term activity modification, analgesics (acetaminophen first-line, with cautious short-course opioids and NSAID use balanced against further bone and GI risk), and physical therapy focused on extension-biased exercises and fall prevention. Calcitonin has modest evidence for acute fracture pain and is still tested on boards. Thoracolumbosacral orthoses (TLSO bracing) are commonly prescribed, though evidence for bracing altering long-term outcomes is weak. Importantly, every conservative plan should include initiation or optimization of osteoporosis pharmacotherapy (bisphosphonates, denosumab, or an anabolic agent such as teriparatide for severe cases), because preventing the next fracture is as important as treating the current one. Vertebral compression fracture treatment with a procedure is generally reserved for patients with persistent, function-limiting pain after a trial of conservative therapy (commonly two to six weeks), or for those with early fractures and severe pain in whom the VAPOUR-trial-style early-intervention data (below) make a stronger procedural case. This staging-to-procedure decision point is exactly the kind of exam-ready material covered in depth in the PainExam Board Review Course, for anyone building toward the ABA Pain Medicine exam.
Percutaneous Vertebroplasty: Step-by-Step Technique
Vertebroplasty injects acrylic bone cement (polymethylmethacrylate, PMMA) directly into the fractured vertebral body without a preceding cavity-creation step. The typical sequence:
- Position the patient prone on a radiolucent table; obtain true AP and lateral fluoroscopic views to confirm the pedicle "owl's eye" appearance and the target level.
- Prep and drape in sterile fashion; administer local anesthesia to skin, subcutaneous tissue, and periosteum at the entry point.
- Advance an 11- to 13-gauge trocar/needle via a transpedicular (most thoracolumbar levels) or parapedicular (common at upper thoracic levels, where pedicles are narrower) approach under biplanar fluoroscopy.
- Confirm needle tip position just past the junction of the anterior and middle thirds of the vertebral body on lateral view, medial to the pedicle wall on AP view.
- Mix PMMA cement to a toothpaste-like viscosity and inject slowly under continuous lateral fluoroscopy, watching closely for any venous or epidural extravasation; stop immediately if cement approaches the posterior vertebral wall or enters a vein.
- Withdraw the trocar while rotating to minimize a cement "tail," and hold pressure at the entry site.
Unilateral transpedicular vertebroplasty with adequate cement cross-filling across the midline is generally sufficient; bipedicular injection is reserved for inadequate unilateral fill.
Balloon Kyphoplasty: Step-by-Step Technique
Kyphoplasty follows the same positioning and needle-access steps as vertebroplasty, but after cannula placement, an inflatable bone tamp (balloon) is advanced through the working cannula into the vertebral body and inflated under fluoroscopic and (on systems with sensors) pressure guidance to create a cavity and, ideally, partially restore vertebral body height before the balloon is deflated and withdrawn. Cement is then injected into the resulting cavity at a lower pressure than vertebroplasty requires, which is the procedural rationale for kyphoplasty's lower reported rate of cement extravasation compared with vertebroplasty. For the boards, remember that both techniques are forms of percutaneous vertebral compression fracture treatment, but the trade-offs differ: kyphoplasty takes longer, costs more, and carries a theoretical (not definitively proven) height-restoration advantage, while vertebroplasty is faster, cheaper, and has the larger and longer-standing randomized evidence base.
Comparing Vertebroplasty, Kyphoplasty, and Conservative Management
A side-by-side comparison is one of the most useful ways to retain this material for both clinical practice and the boards:
| Feature | Vertebroplasty | Balloon Kyphoplasty | Conservative Management |
|---|---|---|---|
| Mechanism | Direct PMMA cement injection, no cavity creation | Balloon-created cavity, then lower-pressure cement fill | Analgesia, bracing, PT, osteoporosis therapy |
| Height restoration | Minimal to none | Modest, inconsistent across trials | None |
| Typical procedure time | 20-30 minutes per level | 30-45 minutes per level | Not applicable |
| Cement leakage risk | Higher reported rates | Lower reported rates | None |
| Strongest RCT evidence | Two large sham-controlled trials (largely negative beyond 1 month) | Less extensive placebo-controlled data | Supported by guideline consensus |
| Best-supported niche | Acute (<6 weeks) fracture with severe pain (VAPOUR data) | Painful fracture with need for height/kyphosis correction | Subacute/chronic pain without red flags |
What the Landmark Trials Show: Buchbinder, Kallmes, and VAPOUR
No discussion of vertebral compression fracture treatment is complete, or board-safe, without the three trials that defined (and complicated) this field. In 2009, two independent randomized, placebo-controlled trials challenged the assumption that vertebroplasty clearly outperforms a sham procedure. Buchbinder and colleagues randomized 78 patients with painful osteoporotic fractures of less than 12 months' duration to vertebroplasty or a simulated procedure (local anesthetic without cement) and found no significant between-group difference in pain or disability at 3 months. Kallmes and colleagues similarly randomized 131 patients to vertebroplasty or a simulated procedure and found no significant difference in pain or the Roland-Morris Disability Questionnaire at one month, though both groups improved substantially, raising the possibility of a strong placebo or natural-history effect.
These two trials reshaped practice patterns and are frequently cited (sometimes overstated) as evidence that "vertebroplasty doesn't work." The more nuanced, board-relevant point is that both trials enrolled fractures of variable and often longer duration, which may have diluted any true treatment effect. The 2016 VAPOUR trial addressed this directly by restricting enrollment to fractures of less than 6 weeks' duration with severe pain, and randomizing 120 patients to vertebroplasty or a sham procedure. VAPOUR found a statistically and clinically significant benefit for vertebroplasty at 14 days (44% of the vertebroplasty group versus 21% of the placebo group achieved a pain score below 4/10) and found the procedure was also safe in this acute population. The honest, exam-ready synthesis: the timing of the procedure relative to fracture onset appears to be the key variable the earlier negative trials did not control for, and vertebral compression fracture treatment decisions should weigh fracture age and severity, not treat all vertebroplasty literature as uniformly negative or uniformly positive.
Complications and Risk Mitigation
Cement extravasation is the complication most tested on exams: it can be asymptomatic, cause radicular pain from foraminal leakage, or, rarely, cause symptomatic pulmonary cement embolism from venous leakage. Reported extravasation rates are higher with vertebroplasty than kyphoplasty, which is attributed to the higher injection pressures vertebroplasty requires in the absence of a pre-formed cavity. Adjacent-level fracture is another well-documented risk, thought to relate to the altered biomechanical loading created by a stiffened, cement-augmented vertebral body transmitting more stress to neighboring levels. Infection, bleeding, and transient neurologic injury from needle malposition round out the major complication list for either vertebral compression fracture treatment approach. Careful posterior-wall assessment on pre-procedure CT or MRI, meticulous lateral fluoroscopic monitoring during injection, and immediate cessation of injection at the first sign of leakage are the principal risk-mitigation strategies.
Board Exam Pearls: (1) MRI STIR hyperintensity, not plain film, is what confirms a vertebral compression fracture is acute. (2) The Genant classification grades height loss severity; AO Spine and OF classifications address injury morphology and instability. (3) Buchbinder and Kallmes (NEJM, 2009) both found no significant benefit of vertebroplasty over sham beyond the immediate post-procedure period. (4) VAPOUR (Lancet, 2016) found a significant benefit when the procedure was performed within 6 weeks of fracture onset. (5) Cement leakage is more common with vertebroplasty than kyphoplasty because kyphoplasty injects cement at lower pressure into a pre-formed cavity. (6) Every patient treated for a vertebral compression fracture needs a concurrent osteoporosis workup, not just a corrected vertebra.
References
The evidence behind this week's discussion of vertebral compression fracture treatment, presented without cherry-picking the favorable result:
- Kallmes DF, Comstock BA, Heagerty PJ, et al. A Randomized Controlled Trial of Vertebroplasty for Osteoporotic Spine Fractures. N Engl J Med. 2009;361(6):569-579. doi:10.1056/NEJMoa0900563. (Found no significant benefit of vertebroplasty over a simulated procedure at 1 month.)
- Buchbinder R, Osborne RH, Ebeling PR, et al. A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures. N Engl J Med. 2009;361(6):557-568. (Found no significant benefit of vertebroplasty over a simulated procedure at 3 months.)
- Clark W, Bird P, Gonski P, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10052):1408-1416. doi:10.1016/S0140-6736(16)31341-1. (Found a significant benefit of vertebroplasty over placebo when performed within 6 weeks of fracture onset.)
Keep Learning
Dr. Rosenblum covers CMS coverage policy and the evidence behind this approach to vertebral compression fracture treatment in more detail on The PainExam Podcast: "CMS on Percutaneous Vertebral Augmentation for Vertebral Compression Fractures." For more procedural videos and board-prep content, visit the NRAP Academy YouTube channel.
For related board review topics on this blog, see Cervical Radiculopathy and C6 Selective Nerve Root Injection, Facet Joint Pain Treatment: RFA, Nerve Stimulation, and PRP, and CRPS Treatment and Diagnosis: ABA Pain Medicine Board Review.
Preparing for the ABA Pain Medicine boards? Our PainExam Pain Management Board Review and Refresher Course covers testable material like vertebral compression fracture treatment, staging, and procedural technique in depth. If you perform or supervise image-guided spine and pain procedures, our Ultrasound Training programs build the hands-on skills that complement fluoroscopic procedures like vertebroplasty and kyphoplasty. You can browse the full catalog at All Courses or check upcoming dates on the CME calendar.
Looking for a pain specialist? Visit RosenblumPain.com or call (718) 436-7246. Patients outside the NYC/Brooklyn area can book a virtual second-opinion consultation through RosenblumPain.com.
Disclaimer: This content is provided for general educational and informational purposes only and is intended for healthcare professionals, trainees, and patients seeking general information. It is not medical advice, does not constitute a diagnosis or treatment recommendation for any individual, and does not create a physician-patient relationship. Treatment decisions must always be individualized by a qualified, licensed healthcare provider based on a patient's specific history, examination, and current evidence-based guidelines. Dr. David Rosenblum, NRAP Academy, and PainExam make no warranties as to the completeness or applicability of this information and assume no liability for actions taken based on it. If you are a patient, please consult your own physician before making any medical decisions, and seek immediate medical attention for any urgent or emergency symptoms.